128 related articles for article (PubMed ID: 29655983)
1. Catalytic asymmetric synthesis of α-methyl-p-boronophenylalanine.
Harada S; Kajihara R; Muramoto R; Jutabha P; Anzai N; Nemoto T
Bioorg Med Chem Lett; 2018 Jun; 28(10):1915-1918. PubMed ID: 29655983
[TBL] [Abstract][Full Text] [Related]
2. A periodic development of BPA and BSH based derivatives in boron neutron capture therapy (BNCT).
Lamba M; Goswami A; Bandyopadhyay A
Chem Commun (Camb); 2021 Jan; 57(7):827-839. PubMed ID: 33399147
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of bis-armed amino acid derivatives via the alkylation of ethyl isocyanoacetate and the Suzuki-Miyaura cross-coupling reaction.
Kotha S; Shah VR; Halder S; Vinodkumar R; Lahiri K
Amino Acids; 2007; 32(3):387-94. PubMed ID: 17031480
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of a novel liposome containing BPA-peptide conjugate for BNCT.
Shirakawa M; Yamamto T; Nakai K; Aburai K; Kawatobi S; Tsurubuchi T; Yamamoto Y; Yokoyama Y; Okuno H; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S88-90. PubMed ID: 19446462
[TBL] [Abstract][Full Text] [Related]
5. L-Phenylalanine preloading reduces the (10)B(n, α)(7)Li dose to the normal brain by inhibiting the uptake of boronophenylalanine in boron neutron capture therapy for brain tumours.
Watanabe T; Tanaka H; Fukutani S; Suzuki M; Hiraoka M; Ono K
Cancer Lett; 2016 Jan; 370(1):27-32. PubMed ID: 26455769
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
[TBL] [Abstract][Full Text] [Related]
7. Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch.
Aromando RF; Trivillin VA; Heber EM; Pozzi E; Schwint AE; Itoiz ME
Oral Oncol; 2010 May; 46(5):355-9. PubMed ID: 20308008
[TBL] [Abstract][Full Text] [Related]
8. Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2.
Wongthai P; Hagiwara K; Miyoshi Y; Wiriyasermkul P; Wei L; Ohgaki R; Kato I; Hamase K; Nagamori S; Kanai Y
Cancer Sci; 2015 Mar; 106(3):279-86. PubMed ID: 25580517
[TBL] [Abstract][Full Text] [Related]
9. Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors.
Takagaki M; Ono K; Oda Y; Kikuchi H; Nemoto H; Iwamoto S; Cai J; Yamamoto Y
Cancer Res; 1996 May; 56(9):2017-20. PubMed ID: 8616843
[TBL] [Abstract][Full Text] [Related]
10. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
11. Assessing the effectiveness of fluorinated and α-methylated 3-boronophenylalanine for improved tumor-specific boron delivery in boron neutron capture therapy.
Hirano F; Kondo N; Murata Y; Sudani A; Temma T
Bioorg Chem; 2024 Jan; 142():106940. PubMed ID: 37939508
[TBL] [Abstract][Full Text] [Related]
12. Boron neutron capture therapy of anterior chamber melanoma with p-boronophenylalanine.
Packer S; Coderre J; Saraf S; Fairchild R; Hansrote J; Perry H
Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):395-403. PubMed ID: 1740371
[TBL] [Abstract][Full Text] [Related]
13. Construction of Boronophenylalanine-Loaded Biodegradable Periodic Mesoporous Organosilica Nanoparticles for BNCT Cancer Therapy.
Tamanoi F; Chinnathambi S; Laird M; Komatsu A; Birault A; Takata T; Doan TL; Mai NXD; Raitano A; Morrison K; Suzuki M; Matsumoto K
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668213
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
[TBL] [Abstract][Full Text] [Related]
15. Enantioselective synthesis of adamantylalanine and carboranylalanine and their incorporation into the proteasome inhibitor bortezomib.
de Bruin G; Mock ED; Hoogendoorn S; van den Nieuwendijk AM; Mazurek J; van der Marel GA; Florea BI; Overkleeft HS
Chem Commun (Camb); 2016 Mar; 52(21):4064-7. PubMed ID: 26894389
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation as MRI probe of the trifluoromethylated p-boronophenylalanine and its alcohol derivative.
Hattori Y; Yamamoto H; Ando H; Kondoh H; Asano T; Kirihata M; Yamaguchi Y; Wakamiya T
Bioorg Med Chem; 2007 Mar; 15(5):2198-205. PubMed ID: 17241787
[TBL] [Abstract][Full Text] [Related]
17. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
18. Intracellular boron accumulation in CHO-K1 cells using amino acid transport control.
Sato E; Yamamoto T; Shikano N; Ogura M; Nakai K; Yoshida F; Uemae Y; Takada T; Isobe T; Matsumura A
Appl Radiat Isot; 2014 Jun; 88():99-103. PubMed ID: 24388319
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution of the boron carriers boronophenylalanine (BPA) and/or decahydrodecaborate (GB-10) for Boron Neutron Capture Therapy (BNCT) in an experimental model of lung metastases.
Trivillin VA; Garabalino MA; Colombo LL; González SJ; Farías RO; Monti Hughes A; Pozzi EC; Bortolussi S; Altieri S; Itoiz ME; Aromando RF; Nigg DW; Schwint AE
Appl Radiat Isot; 2014 Jun; 88():94-8. PubMed ID: 24360862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
